If you're looking to combat dry skin this fall, shop the hydrating La Roche-Posay Toleriane Double Repair Face Moisturizer on ...

When Roche's Genentech gained approval for Ocrevus in 2017, the first-in-class infused drug quickly became the best-selling treatment in a crowded multiple sclerosis (MS) market. Three years later ...

Roche shares fall 3.5% Early study trial showed high rate of temporary side effects JP Morgan analysts say heart rate increase is as a concern Roche plans slower ramp-up of pill dose in next trial ...

ASX chairman Damian Roche will retire next month after four years as head of the board of the sharemarket operator, a period marked by the failed roll-out of critical settlement and clearing ...

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...

On Saturday a brief blackout disrupted a University of Southern California football game. Why aren’t La La Land’s progressive leaders upset? Maybe because they’re partly responsible.